MAIA Biotechnology, Inc.
MAIA
$1.33
$0.021.53%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.56% | -41.01% | -1.59% | -225.41% | 39.78% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.79% | 196.52% | 264.48% | 158.63% | -79.85% |
| Change in Net Operating Assets | 133.06% | -19.48% | -2,001.45% | 38,864.06% | 106.20% |
| Cash from Operations | -63.23% | -26.39% | -79.64% | 1.08% | 11.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 483.27% | -1.18% | 530.16% | -56.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 63.19% | -874.60% | 11.55% | -83.54% | 44.86% |
| Cash from Financing | -101.91% | 468.60% | -0.89% | 575.62% | -57.33% |
| Foreign Exchange rate Adjustments | -126.19% | 354.84% | 41.79% | -110.75% | 55.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -848.43% | 1,940.82% | -345.33% | 125.87% | -121.73% |